Celeste Lindley

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

37h-index6.8kcitations111works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Anesthesia and Pain Management(21), Nausea and vomiting management(19), Cancer Treatment and Pharmacology(16), Pain Management and Opioid Use(12), Pharmacogenetics and Drug Metabolism(11)

Publications111 total

Enantioselective liquid chromatography–mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasma
UNC Libraries·2020Open Access
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
UNC Libraries·2020Open Access
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
UNC Libraries·2020Open Access
G250(P) Are Vulnerable Children Less Likely to be Brought to Clinic Appointments? A Telephone Survey of Parents and Carers to Identify Barriers
2017
The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans
Drug Metabolism and Disposition·2012· 32 citedOpen Access
Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes
Journal of Biochemical and Molecular Toxicology·2009· 46 cited
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
Cancer Chemotherapy and Pharmacology·2008· 28 citedOpen Access
Nelarabine: A novel purine antimetabolite antineoplastic agent
Clinical Therapeutics·2007· 60 cited
Enantioselective liquid chromatography–mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasma
Journal of Pharmaceutical and Biomedical Analysis·2007· 19 citedOpen Access
Plasma pharmacokinetics and cerebrospinal fluid concentrations of erlotinib in high-grade gliomas: A novel, phase I, dose escalation study
Journal of Clinical Oncology·2007· 13 cited
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
Cancer Chemotherapy and Pharmacology·2007· 78 citedOpen Access
273: Safety and efficacy of high-dose busulfan by 90-hour continuous infusion in hematologic malignancy patients undergoing allogeneic stem cell transplants
Biology of Blood and Marrow Transplantation·2007Open Access
Lopinavir/ritonavir Reduces Bupropion Plasma Concentrations in Healthy Subjects
Clinical Pharmacology & Therapeutics·2007· 93 cited
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Clinical Therapeutics·2006· 530 cited
Clinical and Pharmacokinetic Results of a Four-Day Continuous Infusion of Full-Dose Busulfan in Patients (pts) Undergoing Matched Related (MRD) or Unrelated (MUD) Stem Cell Transplant (SCT).
Blood·2005
Bioavailability and Metabolism of Prochlorperazine Administered via the Buccal and Oral Delivery Route
The Journal of Clinical Pharmacology·2005· 35 cited
Pemetrexed: A multitargeted antifolate
Clinical Therapeutics·2005· 137 cited
Intravenous busulfan test dose clearance comparison with first and thirteenth dose systemic exposure in allogenic bone marrow transplantation patients
Journal of Clinical Oncology·2005· 2 cited
90 hour continuous intravenous busulfan infusion: PK and test dose predictability in allogenic bone marrow transplantation patients
Journal of Clinical Oncology·2005· 1 cited
High response rate but significant toxicity with sequential high-dose ifosfamide (I), carboplatin (C), and etoposide (E) with rituximab for relapsed Hodgkin’s (HD) and large cell non-Hodgkin’s lymphoma (NHL)
Journal of Clinical Oncology·2005
page 1 of 6Next →

Frequent Co-authors

Stacy S. Shord(9), Jeannine S. McCune(8), William T. Sawyer(7), Stephanie Faucette(6), Roy L. Hawke(5), Edward L. LeCluyse(5), Stephen A. Bernard(4), Mark A. Socinski(4), S Pescatore(4), Jo Ann Dalton(4), William S. Blau(4), Christine M. Walko(3), Bingfang Yan(3), Anastasia Ivanova(3), Jason M. Collins(3), Elizabeth Claire Dees(3), Eric P. Winer(3), Harold R. Roberts(3), John S. Carlson(3), Richard Youngblood(3)